Cardiovascular Treatment
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
96
NCT06465303
A Study of RTP-026 to Assess Safety, Tolerability and Efficacy in Patients With ST-Elevation Myocardial Infarction (STEMI)
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 16, 2024
Completion: Dec 21, 2025
Loading map...